Nonclinical Factors Predict Selection of Initial Observation for Renal Cell Carcinoma

Urology

Volumn 86, Issue 5, 2015, Pages 892-900

  Maurice, Matthew J ^a,b   Zhu, Hui ^b,c   Kiechle, Jonathan E ^a,b   Kim, Simon P ^a   Abouassaly, Robert ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; AGING; ARTICLE; BILATERAL CANCER; COMMUNITY CARE; COMORBIDITY; FEMALE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITAL CARE; HUMAN; INITIAL OBSERVATION; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; OBSERVATION; POVERTY; PRIORITY JOURNAL; RENAL CELL CARCINOMA; RISK FACTOR; TUMOR VOLUME; CARCINOMA, RENAL CELL; COMPARATIVE STUDY; FACTUAL DATABASE; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; NEPHRECTOMY; PATHOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR INVASION; UNITED STATES; WATCHFUL WAITING;

AGED; BIOPSY, NEEDLE; CARCINOMA, RENAL CELL; DATABASES, FACTUAL; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEPHRECTOMY; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES; WATCHFUL WAITING;

EID: 84983480752     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2015.06.057     Document Type: Article

References (29)

1. Sun, M., Thuret, R., Abdollah, F., et al. Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. Eur Urol 59 (2011), 135–141.
2. Lam, J.S., Shvarts, O., Pantuck, A.J., Changing concepts in the surgical management of renal cell carcinoma. Eur Urol 45 (2004), 692–705.
3. Jewett, M.A., Mattar, K., Basiuk, J., et al. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol 60 (2011), 39–44.
4. Shuch, B., Hanley, J.M., Lai, J.C., et al. Adverse health outcomes associated with surgical management of the small renal mass. J Urol 191 (2014), 301–308.
5. Smaldone, M.C., Kutikov, A., Egleston, B.L., et al. Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer 118 (2012), 997–1006.
6. Pierorazio, P.M., Johnson, M.H., Ball, M.W., et al. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM Registry. Eur Urol 68 (2015), 408–415.
7. Campbell, S.C., Novick, A.C., Belldegrun, A., et al. Guideline for management of the clinical T1 renal mass. J Urol 182 (2009), 1271–1279.
8. Ljungberg, B., Bensalah, K., Canfield, S., et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67 (2015), 913–924.
9. Abouassaly, R., Lane, B.R., Novick, A.C., Active surveillance of renal masses in elderly patients. J Urol 180 (2008), 505–509.
10. Hollenbeck, B.K., Taub, D.A., Miller, D.C., et al. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization?. Urology 67 (2006), 254–259.
11. Kim, S.P., Shah, N.D., Weight, C.J., et al. Contemporary trends in nephrectomy for renal cell carcinoma in the United States: results from a population based cohort. J Urol 186 (2011), 1779–1785.
12. Patel, S.G., Penson, D.F., Pabla, B., et al. National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats. J Urol 187 (2012), 816–821.
13. Cooperberg, M.R., Mallin, K., Kane, C.J., et al. Treatment trends for stage I renal cell carcinoma. J Urol 186 (2011), 394–399.
14. Yang, G., Villalta, J.D., Meng, M.V., et al. Evolving practice patterns for the management of small renal masses in the USA. BJU Int 110 (2012), 1156–1161.
15. Jacobs, B.L., Tan, H.J., Montgomery, J.S., et al. Understanding criteria for surveillance of patients with a small renal mass. Urology 79 (2012), 1027–1032.
16. Smaldone, M.C., Churukanti, G., Simhan, J., et al. Clinical characteristics associated with treatment type for localized renal tumors: implications for practice pattern assessment. Urology 81 (2013), 269–275.
17. Chawla, S.N., Crispen, P.L., Hanlon, A.L., et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175 (2006), 425–431.
18. Abouassaly, R., Yang, S., Finelli, A., et al. What is the best treatment strategy for incidentally detected small renal masses? A decision analysis. BJU Int 108 (2011), E223–E231.
19. Duffey, B.G., Choyke, P.L., Glenn, G., et al. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol 172 (2004), 63–65.
20. Thompson, R.H., Hill, J.R., Babayev, Y., et al. Metastatic renal cell carcinoma risk according to tumor size. J Urol 182 (2009), 41–45.
21. Gellert, L.L., Mehra, R., Chen, Y.B., et al. The diagnostic accuracy of percutaneous renal needle core biopsy and its potential impact on the clinical management of renal cortical neoplasms. Arch Pathol Lab Med 138 (2014), 1673–1679.
22. Herring, J.C., Enquist, E.G., Chernoff, A., et al. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J Urol 165 (2001), 777–781.
23. Becker, A., Roghmann, F., Trinh, Q.D., et al. Sociodemographic disparities in the treatment of small renal masses. BJU Int 111 (2013), E274–E282.
24. Maurice, M.J., Zhu, H., Abouassaly, R., A hospital-based study of initial observation for low-risk prostate cancer and its predictors in the United States. Can Urol Assoc J 9 (2015), E193–E199.
25. Gray, P.J., Fedewa, S.A., Shipley, W.U., et al. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base. Eur Urol 63 (2013), 823–829.
26. Zini, L., Perrotte, P., Capitanio, U., et al. Race affects access to nephrectomy but not survival in renal cell carcinoma. BJU Int 103 (2009), 889–893.
27. Kates, M., Whalen, M.J., Badalato, G.M., et al. The effect of race and gender on the surgical management of the small renal mass. Urol Oncol 31 (2013), 1794–1799.
28. Chang, S.L., Cipriano, L.E., Harshman, L.C., et al. Cost-effectiveness analysis of nephron sparing options for the management of small renal masses. J Urol 185 (2011), 1591–1597.
29. Bilimoria, K.Y., Bentrem, D.J., Stewart, A.K., et al. Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. J Clin Oncol 27 (2009), 4177–4181.